EGFR, epidermal growth factor receptor, is a protein found on the surface of your cells that makes them grow. If you have non-small-cell lung cancer (NSCLC), your cancer might carry certain ...

If you have EGFR-positive lung cancer, you have some choices to make about treatment options. Especially if your cancer is advanced. Your doctors can help you choose from a list of approved drugs ...

A schematic diagram showing the significant contribution of SCoV2-induced altered mitochondrial dynamics and mitochondrial EGFR translocation in sustaining viral propagation. First, SCOV2 RNA and ...

They found both previously known and novel mutations significantly linked to EGFR activation and drug response, demonstrating the method's precision and revealing new pathways affecting tumor ...

Please provide your email address to receive an email when new articles are posted on . Newer eGFR calculations that do not consider race show a link between kidney function and dementia.

Osimertinib is the leading treatment for patients with EGFR-mutant NSCLC, but resistance mutations, including L858R/C797S and L858R/T790M/C797S, have emerged in the clinic.

A novel topical formulation of a BRAF inhibitor significantly reduced acneiform rash associated with anti–epidermal growth factor receptor (EGFR) therapies in patients with colorectal cancer ...

Patients with lung cancer treated with epidermal growth factor receptor (EGFR) inhibitors may have an increased risk of new-onset keratitis, a U.S. population-based cohort study showed.

They also discovered that the virus manipulates the EGFR protein, which is critical for cellular growth signaling, to maintain this rapid replication. This increases the likelihood of the virus ...